Показано 0 из 0
Дата |
---|
10:04 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
45.10
|
45.70
|
45.80
|
45.80
|
45.80
|
45.80
|
|
|
|
|
44.80
|
45.40
|
47.30
|
47.30
|
47.30
|
47.30
|
|
|
|
|
47.40
|
47.90
|
44.20
|
44.20
|
44.20
|
44.20
|
|
|
|
|
42.90
|
43.80
|
40.30
|
40.30
|
42.80
|
42.80
|
|
|
3 761.00
|
3.00
|
40.20
|
40.70
|
39.90
|
39.90
|
39.90
|
39.90
|
|
|
|
|
39.50
|
40.30
|
40.30
|
39.60
|
40.30
|
39.90
|
|
|
23 850.00
|
3.00
|
40.20
|
41.00
|
38.90
|
38.90
|
38.90
|
38.90
|
|
|
|
|
38.40
|
38.90
|
39.00
|
39.00
|
39.00
|
39.00
|
|
|
|
|
37.60
|
38.20
|
37.60
|
37.60
|
37.60
|
37.60
|
|
|
|
|
36.80
|
37.60
|
39.00
|
39.00
|
39.00
|
39.00
|
|
|
|
|
Gubra is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P).